Dipeptidyl peptidase-4 inhibitor

Inhibitors of dipeptidyl peptidase 4, also DPP-4 inhibitors or gliptins, are a class of oral hypoglycemics that block DPP-4 (DPP-IV). They can be used to treat diabetes mellitus type 2.
The first agent of the class - sitagliptin - was approved by the FDA in 2006.